Electron beam intraoperative radiation therapy system Mobetron

breast cancer treeatmentpancreatic cancer treatmentmobile

For surgical oncologists, Mobetron serves a critical collaborative role in efficiently and effectively delivering an ablative dose of radiation directly to the tumor bed at the optimal biological time. It ensures confidence among surgical specialists that microscopic and residual cancers have been effectively treated. Electron Beam IORT Affirmed by ASTRO In its most recent APBI Consensus Statement, ASTRO offered “published evidence complemented by expert opinion” in distinguishing Mobetron from all other IORT treatment options available in the fight against breast cancer. In fact, electron IORT — as performed with the Mobetron— is the only single treatment radiation option for suitable patients affirmed by the ASTRO consensus. The End of the Shielded OR By enabling truly patient-specific treatment among surgeons and radiation oncologists, Mobetron improves efficiency by reducing treatment from weeks to minutes. And it gets entire surgical teams into the OR and up and running quickly. Faster treatment times mean fewer personnel are required and a greater number of patients may be treated. All of this equates to being able to focus on increased productivity and maximizing economics. Time is critical and shorter treatment times deliver a host of benefits. But it doesn’t end there. Mobetron is also the tool that surgical teams can configure for their most efficient workflows. Mobetron’s thin-walled applicators provide virtually no dose to the skin and may be conformed to a variety of anatomical structures and tumor geometries.